biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦11:51 Putting force on old mice's leg bones helped them live about 9% longer✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦11:54 Cold helps worms live longer via a chemical their muscles send out✦06:14 Menopause brings sudden body-wide changes, not a slow slide, study says✦11:51 Putting force on old mice's leg bones helped them live about 9% longer✦06:17 Stem cell implants helped 9 Parkinson's patients move better, maker says✦05:42 Siblings born deaf respond to sounds after a newly approved gene therapy✦06:20 US gives up to $41M to test existing drugs for preventing Alzheimer's✦06:18 80-year-old's blood cells become brain stem cells that test under age 20✦05:46 Pill meant to help older dogs live longer is one FDA step from approval✦11:54 Cold helps worms live longer via a chemical their muscles send out
← All story threadsSTORY THREAD

NewLimit's drugs to make old cells act younger.

1 report so far. New developments are added to this thread as they happen.

  1. Jun 2, 2026
    RAISES $435M TO REACH A FIRST HUMAN TRIALCompany news · no human data

    Coinbase founder's anti-aging startup raises $435M, plans first human trial

    NewLimit, co-founded by Coinbase's Brian Armstrong, raised $435 million to bring a drug meant to make old liver cells act younger into its first human test, planned for 2027.